Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2011
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011
Report date:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
4'-benzyloxy-2-bromopropiophenone
EC Number:
252-351-6
EC Name:
4'-benzyloxy-2-bromopropiophenone
Cas Number:
35081-45-9
Molecular formula:
C16H15BrO2
IUPAC Name:
1-[4-(benzyloxy)phenyl]-2-bromopropan-1-one
Test material form:
solid: particulate/powder

In vivo test system

Study design: in vivo (LLNA)

Vehicle:
dimethylformamide
Concentration:
Test item concentrations of 10, 25, and 50% (w/v).

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Remarks:
at concentration of 10% w/v in DMF
Value:
28.21
Parameter:
SI
Remarks:
at concentration of 25% w/v in DMF
Value:
31.12
Parameter:
SI
Remarks:
at concentration of 50% w/v in DMF
Value:
32.64

Applicant's summary and conclusion

Interpretation of results:
Category 1 (skin sensitising) based on GHS criteria
Conclusions:
The test item TSE-1 was found to be a skin sensitiser under the described conditions. In view of these results, according to the Regulation (EC) No. 1272/2008 on classification, labeling and packaging (CLP) of substances and mixtures, the test item is classified as "skin sensitiser category 1, H317 (“May cause an allergic skin reaction”)". According to the former European Dangerous Substance Directive (Council Directive 67/548/EEC, currently undergoing a phase-out process), the test item is classified as sensitizing and assigned the symbol “Xi”, the indication of danger “Irritant” and the risk phrase R43 ("may cause sensitisation by skin contact”).